insights_auto
Why is NXTCL down 5.62%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEKÂ 0.23
arrow_downward
-5.62%(-0.013) 1D
Nov 16, 5:12:13 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEKÂ 0.26
High
SEKÂ 0.26
Low
SEKÂ 0.22
Mkt. cap
28.63M
Avg. vol.
1.00M
Volume
396.66K
52-wk high
SEKÂ 1.78
52-wk low
SEKÂ 0.20
EPS
-SEKÂ 0.45
Shares outstanding
111.39M
No. of employees
21
Open
SEKÂ 0.26
High
SEKÂ 0.26
Low
SEKÂ 0.22
Mkt. cap
28.63M
Avg. vol.
1.00M
Volume
396.66K
52-wk high
SEKÂ 1.78
52-wk low
SEKÂ 0.20
EPS
-SEKÂ 0.45
Shares outstanding
111.39M
No. of employees
21
News stories
From web sources and news partners
Bloomberg.com
·
1 hour ago
Wells Fargo Sees S&P 500 at 8,200 By End of 2027 as Profits Slow
marketscreener.com
·
2 hours ago
Nasdaq, S&P 500 Fall For Third Day as Nvidia Sell-Off Continues
Investing.com
·
2 hours ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
Traders Union
·
59 minutes ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
FoundedMar 19, 2014
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitenextcellpharma.com